Business Description
Nutriband Inc
NAICS : 339113
SIC : 2834
ISIN : US67092M2089
Total Employee Number:
3Description
Nutriband Inc is engaged in the development of a portfolio of transdermal pharmaceutical products. AVERSA technology is the company's product that incorporates aversive agents to prevent the Abuse, Diversion, Misuse, and Accidental exposure of drugs with abuse potential specifically Opioids. Company operates in two reportable segments namely, Sales of Goods and Services. The majority of the revenue is generated from the sale of goods that include consumer transdermal and coated products.
Financial Strength
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 17.19 | |||||
Equity-to-Asset | 0.87 | |||||
Debt-to-Equity | 0.04 | |||||
Debt-to-EBITDA | -0.03 | |||||
Piotroski F-Score | 4/9 | |||||
Altman Z-Score | 12.27 | |||||
Beneish M-Score | -6.18 | |||||
WACC vs ROIC | ||||||
Growth Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | -10.7 | |||||
3-Year EBITDA Growth Rate | -12 | |||||
3-Year EPS without NRI Growth Rate | -73.9 | |||||
3-Year FCF Growth Rate | -6.9 | |||||
3-Year Book Growth Rate | -20.5 |
Momentum Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 32.4 | |||||
9-Day RSI | 36.94 | |||||
14-Day RSI | 38.54 | |||||
3-1 Month Momentum % | -12.56 | |||||
6-1 Month Momentum % | -21.97 | |||||
12-1 Month Momentum % | -58.41 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 5.26 | |||||
Quick Ratio | 5.11 | |||||
Cash Ratio | 4.81 | |||||
Days Inventory | 41.2 | |||||
Days Sales Outstanding | 21.23 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | -15.8 | |||||
Shareholder Yield % | -14.21 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 28.41 | |||||
Operating Margin % | -452.72 | |||||
Net Margin % | -448.5 | |||||
EBITDA Margin % | -437.9 | |||||
FCF Margin % | -241.95 | |||||
OCF Margin % | -241.95 | |||||
ROE % | -119.5 | |||||
ROA % | -103.12 | |||||
ROIC % | -289.66 | |||||
3-Year ROIIC % | 100.82 | |||||
ROC (Joel Greenblatt) % | -1191.9 | |||||
ROCE % | -117.52 | |||||
Moat Score | 2 | |||||
Tariff Resilience Score | 4 |
GF Value Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 2.04 | |||||
PS Ratio | 19.34 | |||||
PB Ratio | 6.04 | |||||
Price-to-Tangible-Book | 8.71 | |||||
EV-to-EBIT | -4 | |||||
EV-to-EBITDA | -4.08 | |||||
EV-to-Forward-EBITDA | 146.44 | |||||
EV-to-Revenue | 17.88 | |||||
EV-to-Forward-Revenue | 6.84 | |||||
EV-to-FCF | -7.39 | |||||
Price-to-GF-Value | 0.91 | |||||
| Price-to-Net-Current-Asset-Value | 10.21 | |||||
| Price-to-Net-Cash | 11.38 | |||||
Earnings Yield (Greenblatt) % | -25 | |||||
FCF Yield % | -12.12 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:NTRB
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Nutriband Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 1.802 | ||
| EPS (TTM) ($) | -2.58 | ||
| Beta | 2.2255 | ||
| 3-Year Sharpe Ratio | 0.34 | ||
| 3-Year Sortino Ratio | 0.75 | ||
| Volatility % | 37.34 | ||
| 14-Day RSI | 38.54 | ||
| 14-Day ATR ($) | 0.215942 | ||
| 20-Day SMA ($) | 3.1405 | ||
| 12-1 Month Momentum % | -58.41 | ||
| 52-Week Range ($) | 2.9 - 9.2069 | ||
| Shares Outstanding (Mil) | 12.16 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Nutriband Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Nutriband Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Third quarter earnings results for 2026 | 2026-12-11 | In 153 days | ||
| Second quarter earnings results for 2026 | 2026-09-10 | In 61 days | ||
| First quarter earnings results for 2026 | 2026-06-11 | 3.41 (-3.40%) | ||
| Annual report for 2025 | 2026-04-29 | 3.76 (-1.05%) | ||
| General meeting for 2025 | 2026-01-24 10:00 | 4.80 (+6.67%) | ||
| Third quarter earnings results for 2025 | 2025-12-11 | 4.89 (+1.88%) | ||
| Noble Capital Markets\' Twenty First Annual Emerging Growth Equity Conference | 2025-12-03 09:30 | 4.62 (-6.67%) | ||
| Noble Capital Markets’ Emerging Growth Virtual Equity Conference | 2025-10-08 15:00 | 7.84 (+3.98%) | ||
| MicroCap Rodeo Conference | 2025-09-25 12:30 | 7.27 (+2.68%) | ||
| Second quarter earnings results for 2025 | 2025-09-10 | 6.08 (-2.09%) |
Show
Entries
Nutriband Inc Frequently Asked Questions
What is Nutriband Inc(NTRB)'s stock price today?
The current price of NTRB is $2.96. The 52 week high of NTRB is $9.21 and 52 week low is $2.90.
When is next earnings date of Nutriband Inc(NTRB)?
The next earnings date of Nutriband Inc(NTRB) is 2026-09-10 Est..
Does Nutriband Inc(NTRB) pay dividends? If so, how much?
Nutriband Inc(NTRB) does not pay dividend.
Guru Commentaries on NAS:NTRB
No articles.
Press Release
Articles on Nutriband Inc
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers